Sindrom keradangan multisistem pediatrik (PMIS/PIMS/PIMS-TS) | |
---|---|
Nama lain |
|
Imej TEM SARS-CoV-2, koronavirus yang bertanggungjawab terhadap COVID-19: PMIS / MIS-C dikatakan telah diakibatkan oleh tindak balas biologi luar biasa jangkitan terhadap kanak-kanak | |
Pengkhususan | Pediatrik |
Gejala | Fever, kesakitan abdomen, diarea/muntah, tekanan darah rendah, bekalan darah tidak mencukupi (kejutan), mata merah jambu, "lidah strawberi", ruam, limfus noda besar, tangan/kaki nengkak, gangguan neurologi, among others |
Kerumitan | Cardiac dysfunction; coronary artery abnormalities, including aneurysms; acute kidney injury; coagulopathy |
Permulaan biasa | typically 2–6 weeks after COVID-19 exposure |
Punca | Koronavirus sindrom pernafasan akut teruk 2 (SARS-CoV-2) |
Clinical evaluation by specialists | |
Alternative infectious/non-infectious causes, penyakit Kawasaki | |
Rawatan | Intravenous immunoglobulin (IVIG); kortikosteroid; oxygen, supportive care |
Prognosis | Response to treatment, generally good; long-term prognosis, unclear |
Kekerapan | Rare |
Kematian | <2% of reported cases |
sunting |
Sindrom keradangan multisistem pada kanak-kanak (MIS-C), atau sindrom multisistem keradangan pediatrik (PIMS / PIMS-TS), ialah penyakit sistemik jarang berlaku yang melibatkan demam terus-menerus dan keradangan ekstrem setelah dijangkiti SARS-CoV-2, virus yang menyebabkan COVID-19.
Rujukan
- ^ "Case Report Form for suspected cases of multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19". www.who.int (dalam bahasa Inggeris). World Health Organization. Diarkibkan daripada yang asal pada 24 June 2020.
Pautan luar
- Fact sheet for parents released by New York City's Health Department
- Information for parents provided by the Children's Hospital Los Angeles
- Information for paediatric health care providers in the U.S.A. (from the CDC)